{"name":"R-Pharm Overseas, Inc.","slug":"r-pharm-overseas-inc","ticker":"","exchange":"","domain":"","description":"R-Pharm Overseas, Inc. is a biopharmaceutical company focused on the development of innovative therapies. The company's lead candidate, RPH-104, is currently in Phase 3 clinical trials, while another formulation, 80 mg RPH-104, has been discontinued.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RPH-104","genericName":"RPH-104","slug":"rph-104","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"RPH-104","genericName":"RPH-104","slug":"rph-104","phase":"phase_3","mechanism":"RPH-104 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNT1pOV0lrMzBTaGl1NGJ6M0I2WGluTzhJeHM2dnhZSmthMHZ6ai1EaWRwQ2pkY1F4Y0hEWDJSOGw1NWRReDlDeHV4Q211UU4xUk93LWsweEs0Y3JyT2wwNkM2eVJFdm5NMk1pclgyT1ZGTVhOSkkyX3B6RTJPTmx3WUpHRHZUWkFWOC1taFpmUnVhcFMzWUprQmFSak9XeUl3QnNGaThoX1lkbng5b3RuN0s0MVZhdG8?oc=5","date":"2025-08-05","type":"pipeline","source":"Reuters","summary":"Moscow-based pharma firm sues Raiffeisenbank for 337.5 million euros - Reuters","headline":"Moscow-based pharma firm sues Raiffeisenbank for 337.5 million euros","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPdHp5aDF0NGFnNHl5bGs4QUZ2TndrTXR1WnF4dVR1LWlRd0ZzQV9lbmpUaDBvY01RSzVpSEFXYnUzRHRLVTdmU0I5bFdVUUFkVUhCclhTeHJYWlIyTW5RN253SFRpWWN0Wm1DZEwzRnREaFk3alFzZ2djYjFlQkl3U2lUcUFhTmpHb2NaZHpVbHJqLUlnWTh5LS16OFEyM2lQaEJRSGVFOExxUm9ZbXN2ZW9XeWcwRVFMV0R5MjJRS19fakhZZVdteVl6XzFtdDNGVHNiUEtR?oc=5","date":"2024-07-23","type":"pipeline","source":"washingtonexaminer.com","summary":"Pharmacy middlemen moving overseas as regulations loom, House Republican investigation claims - washingtonexaminer.com","headline":"Pharmacy middlemen moving overseas as regulations loom, House Republican investigation claims","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE1Cb25LZFNlbkMxcEZMbHhnRzZlbWhLX3hseEFCM0ZHYWFUaE9rWjBZTHlxbXJrSU1CRGk4U1RETkFNZ3hzcVlrZFJSakhYSDhOYVlNUU40bHVKVWcxSFdFZkh1WlJEc1U1dFNZ?oc=5","date":"2020-07-31","type":"pipeline","source":"Pharmaceutical Executive","summary":"Emerging Pharma Leaders 2014 - Pharmaceutical Executive","headline":"Emerging Pharma Leaders 2014","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPLU02d1dZSFNHajRTTHFNakdLRjhldTVoRm1hQTd2SkRRTFp5ODNkQjFnMElCX2RscDBmbE1ybGNlWE5zSmIwMFNLUXJNcFNTSjNlcWJIb0xSZ0tvZkozRFQzLWpHdjlYQ1JBZG9RMUVpaFdrbzNrTDltVUR1YURvZlFsVTFIWDBfZGFsSy0tVGZQbWRpSzZub9IBngFBVV95cUxQbkVpLWFFdVNDNUV1UFk0UUhIc0ZyTmM4NWRWdU1PQ0tKdmFUSmJYSjFkTVpxZ3pxT2ZBNWdndUZBZTV1TGtPcnZtZTVwdGhqUU8zY0M4Qk50RmJORS1lZTRCQnQ2SzJpTmtWZTE2bVhkNWZUWURBbkE4OVF0RFVHeHBDWkdLeEM0eVNDZmlha251bXpnZzY3bVo1UlJKUQ?oc=5","date":"2016-08-28","type":"pipeline","source":"The Korea Times","summary":"Kanarb seeks to expand global presence - The Korea Times","headline":"Kanarb seeks to expand global presence","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}